| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 99 |
| 1 | FINGOLIMOD HYDROCHLORIDE | 34 |
| 2 | FINGOLIMOD | 32 |
| 3 | PREDNISOLONE | 12 |
| 4 | PREDNISOLONE ORAL | 12 |
| 5 | PREDNISOLONE ORAL SOLUTION | 12 |
| 6 | ADALIMUMAB-AATY | 10 |
| 7 | LEFLUNOMIDE | 10 |
| 8 | METHOTREXATE | 10 |
| 9 | METHOTREXATE SODIUM | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FINGOLIMOD HYDROCHLORIDE | 34 | 0.0067 |
| 1 | FINGOLIMOD HCL | 99 | 0.0011 |
| 2 | PREDNISOLONE SODIUM PHOSPHATE | 1 | 0.0004 |
| 3 | ALEMTUZUMAB | 5 | 0.0003 |
| 4 | UBLITUXIMAB | 1 | 0.0003 |
| 5 | AMANTADINE HYDROCHLORIDE | 1 | 0.0002 |
| 6 | ADALIMUMAB-AATY | 10 | 0.0002 |
| 7 | ADALIMUMAB-FKJP | 9 | 0.0002 |
| 8 | OFATUMUMAB | 6 | 0.0002 |
| 9 | ADALIMUMAB-ADAZ | 9 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 32 | 0.0023 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 5 | 0.0003 |
| 2 | Interleukin-17A Antagonist [EPC] | 9 | 0.0002 |
| 3 | Integrin Receptor Antagonist [EPC] | 21 | 0.0002 |
| 4 | Pyrimidine Synthesis Inhibitor [EPC] | 6 | 0.0001 |
| 5 | Antirheumatic Agent [EPC] | 10 | 0.0001 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 15 | 0.0000 |
| 7 | Interferon beta [EPC] | 8 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |